Patents: Should We Change Our Intellectual Property Model/Strategies?

By Girish Malhotra In the last thirty-five years about 351,000 US patents (1) were classified in 424 and 514 class category i.e. they are drugs related. This translates to about 10,000 patents per year. I am told that an average US patent (2) (up to 20 pages. Costs go up as the number of pages […]

Are patents a double-edged sword? Perspective Matters.

By Girish Malhotra Patents are filed to preserve intellectual property for the duration of the patent life. This is the fundamental right of every inventor as they protect their invention from competitors and gives them competitive advantage. Pharmaceuticals have relied on this right to preserve their inventions. These patents are a treasure trove for the […]